BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 653646)

  • 1. [Long-term treatment of essential hypertension with hydralazine and alprenolol].
    Pape JF; Pytte R; Fauchald P
    Tidsskr Nor Laegeforen; 1978 Apr; 98(11):552-5. PubMed ID: 653646
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination therapy with alprenolol and hydralazine in essential hypertension. A controlled clinical study].
    Pape J
    Tidsskr Nor Laegeforen; 1973 May; 93(15):1139-42. PubMed ID: 4584539
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of alprenolol in combination with hydralazine in essential hypertension. A double-blind, crossover study and a long-term follow-up study.
    Pape J
    Acta Med Scand Suppl; 1974; 554():55-62. PubMed ID: 4593674
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydralazine slow-release: observations on serum profile and clinical efficacy in man.
    Talseth T; Fauchald P; Pape JF
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):157-68. PubMed ID: 403050
    [No Abstract]   [Full Text] [Related]  

  • 5. A long-term study of the antihypertensive effect of alprenolol.
    Comerford MB; Pringle A
    Acta Med Scand Suppl; 1974; 554():15-22. PubMed ID: 4593669
    [No Abstract]   [Full Text] [Related]  

  • 6. Alprenolol in hypertension.
    Johnsson G
    Acta Med Scand Suppl; 1974; 554():5-7. PubMed ID: 4593675
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma renin concentration in essential hypertension during beta-adrenergic blockade and vasodilator therapy.
    Pedersen EB; Kornerup HJ
    Eur J Clin Pharmacol; 1977 Oct; 12(2):93-6. PubMed ID: 923630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-blockaders in hypertension].
    Erikssen J; Storm-Mathisen H
    Tidsskr Nor Laegeforen; 1973 Sep; 93(25):1780-4. PubMed ID: 4149223
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of alprenolol and hydralazine on plasma renin concentration in patients with arterial hypertension.
    Pedersen EB; Kornerup HJ
    Acta Med Scand; 1975 Nov; 198(5):379-83. PubMed ID: 1199814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
    Hartikainen M; Heikkilä J
    Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alprenolol and alphamethyl-dopa in untreated cases of essential hypertension--a comparison].
    Bergstrand RH; Vedin JA; Wilhelmsson CE
    Lakartidningen; 1973 Aug; 70(33):2817-20. PubMed ID: 4597664
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hypertension using propranolol combined with hydralazine and a thiazidine diuretic. 1st results].
    Díaz de Losada JM
    Rev Clin Esp; 1975 Dec; 139(6):559-62. PubMed ID: 1215599
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with the combination of beta receptor blockader and hydralazine in the treatment of hypertension].
    Jensen HE; Rasmussen K
    Ugeskr Laeger; 1976 Mar; 138(14):860-3. PubMed ID: 772901
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of multiple and combination tablet drug therapy in hypertension.
    David NA; Welborn WS; Pierce HI
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):741-54. PubMed ID: 813939
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and tolerability of hydralazine, in conventional and slow-release preparations, during long-term treatment of primary hypertension.
    Lins LE; Berglund J; Eliasson K; Wernersson B
    Clin Ther; 1983; 5(3):251-9. PubMed ID: 6850719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
    Fea F; Salvioli G; Planca E; Pelliccioli I; Foti F; Colombo G
    Boll Soc Ital Cardiol; 1981; 26(12):2173-82. PubMed ID: 7185386
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined clonidine and hydralazine therapy in severe and refractory hypertension.
    Velasco M; Guevara J; Urbina-Quintana A; Hernández-Pieretti O
    Acta Cient Venez; 1977; 28(5):342-5. PubMed ID: 602602
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hypertension with alprenolol and hydralazine].
    Vedin A; Werkö L; Wilhelmsson C
    Lakartidningen; 1971 Oct; 68(44):5005-8. PubMed ID: 5135955
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Adv Clin Pharmacol; 1976; 11():1114-8. PubMed ID: 802071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.